🚨EX-X CEO YACCARINO #JOINS EMED TO LEAD GLP-1 Push

Linda Yaccarino, former X CEO, now leads eMed, a telehealth startup tackling GLP-1 weight loss drug management.

🔹Despite no health background, she brings marketing prowess to scale the platform, which partners with employers and governments.

🔹eMed claims it can cut treatment costs by 50%. Yaccarino aims to reshape digital healthcare, entering a booming, yet tightly scrutinized, weight-loss pharma-tech race.